Barriers for a HIV cure: the latent reservoir

Sergio Castro-Gonzalez, Marta Colomer-Lluch, Ruth Serra Moreno

Research output: Contribution to journalArticle

Abstract

Thirty-five years after the identification of HIV-1 as the causative agent of AIDS, we are still in search of vaccines and treatments to eradicate this devastating infectious disease. Progress has been made in understanding the molecular pathogenesis of this infection, which has been crucial for the development of the current therapy regimens. However, despite their efficacy at limiting active viral replication, these drugs are unable to purge the latent reservoir: a pool of cells that harbor transcriptionally inactive, but replication-competent, HIV-1 proviruses, and that represent the main barrier to eradicate HIV-1 from affected individuals. In this review, we discuss advances in the field that have allowed a better understanding of HIV-1 latency, including the diverse cell types that constitute the latent reservoir, factors influencing latency, tools to study HIV-1 latency as well as current and prospective therapeutic approaches to target this pool of latently infected cells, so
Original languageEnglish
JournalAIDS Research and Human Retroviruses
StatePublished - Aug 28 2018

Fingerprint Dive into the research topics of 'Barriers for a HIV cure: the latent reservoir'. Together they form a unique fingerprint.

  • Cite this